Cargando…

The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both

The aryl hydrocarbon receptor (AHR) has long been studied by toxicologists as a ligand-activated transcription factor that is activated by dioxin and other environmental pollutants such as polycyclic aromatic hydrocarbons (PAHs). The hallmark of AHR activation is the upregulation of the cytochrome P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Julliard, Walker, Fechner, John H., Mezrich, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183121/ https://www.ncbi.nlm.nih.gov/pubmed/25324842 http://dx.doi.org/10.3389/fimmu.2014.00458

Ejemplares similares

Modeling the Effect of the Aryl Hydrocarbon Receptor on Transplant Immunity
por: Julliard, Walker, et al.
Publicado: (2017)

Exposure to Atmospheric Particulate Matter Enhances Th17 Polarization through the Aryl Hydrocarbon Receptor
por: van Voorhis, Michael, et al.
Publicado: (2013)

The Aryl Hydrocarbon Receptor in Asthma: Friend or Foe?
por: Poulain-Godefroy, Odile, et al.
Publicado: (2020)

The Aryl Hydrocarbon Receptor as an Immune-Modulator of Atmospheric Particulate Matter-Mediated Autoimmunity
por: O'Driscoll, Chelsea A., et al.
Publicado: (2018)

The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
por: Mo, Yenan, et al.
Publicado: (2020)

Polycyclic aromatic hydrocarbons (PAHs) present in ambient urban dust drive proinflammatory T cell and dendritic cell responses via the aryl hydrocarbon receptor (AHR) in vitro
por: O’Driscoll, Chelsea A., et al.
Publicado: (2018)

Platelets in Neurodegenerative Conditions—Friend or Foe?
por: Leiter, Odette, et al.
Publicado: (2020)

The Aryl Hydrocarbon Receptor and Tumor Immunity
por: Xue, Ping, et al.
Publicado: (2018)

Oxygen: both friend and foe
por: Purvis, J
Publicado: (2018)

The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2022)

The Schistosoma Granuloma: Friend or Foe?
por: Hams, Emily, et al.
Publicado: (2013)

Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor
por: Li, Shiyang, et al.
Publicado: (2018)

Arginase in the Vascular Endothelium: Friend or Foe?
por: Lucas, Rudolf, et al.
Publicado: (2014)

ICOS Co-Stimulation: Friend or Foe?
por: Wikenheiser, Daniel J., et al.
Publicado: (2016)

Interleukin-33 in Malignancies: Friends or Foes?
por: Shen, Jia-Xin, et al.
Publicado: (2018)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Heme on Pulmonary Malaria: Friend or Foe?
por: Pádua, Tatiana Almeida, et al.
Publicado: (2020)

Microglia in Multiple Sclerosis: Friend or Foe?
por: Guerrero, Brooke L., et al.
Publicado: (2020)

Role of Lactate in Inflammatory Processes: Friend or Foe
por: Manosalva, Carolina, et al.
Publicado: (2022)

Polycyclic Aromatic Hydrocarbons Affect Rheumatoid Arthritis Pathogenesis via Aryl Hydrocarbon Receptor
por: Xi, Xiaoyu, et al.
Publicado: (2022)

The angiogenic factors and their soluble receptors in sepsis: friend, foe, or both?
por: Zhang, Ru-Yuan, et al.
Publicado: (2013)

Exosomes and Immune Response in Cancer: Friends or Foes?
por: Barros, Francisco M., et al.
Publicado: (2018)

Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
por: Locy, Hanne, et al.
Publicado: (2018)

Tim-4 in Health and Disease: Friend or Foe?
por: Liu, Wen, et al.
Publicado: (2020)

Cytomegaloviruses and Macrophages—Friends and Foes From Early on?
por: Baasch, Sebastian, et al.
Publicado: (2020)

Lactobacillus: Friend or Foe for Systemic Lupus Erythematosus?
por: Wang, Weijie, et al.
Publicado: (2022)

Natural killer cells in sepsis: Friends or foes?
por: Wang, Fangjie, et al.
Publicado: (2023)

Heterogeneity in functional genetic screens: friend or foe?
por: Vredevoogd, David W., et al.
Publicado: (2023)

Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5(+) Innate-Like B Cells
por: Blevins, Lance K., et al.
Publicado: (2021)

The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity
por: Torti, Maria Florencia, et al.
Publicado: (2021)

Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor
por: De Juan, Alba, et al.
Publicado: (2021)

The Complement System at the Embryo Implantation Site: Friend or Foe?
por: Bulla, R., et al.
Publicado: (2012)

CD8(+) T Cells in Leishmania Infections: Friends or Foes?
por: Stäger, Simona, et al.
Publicado: (2012)

Editorial: NK Cells in Human Diseases: Friends or Foes?
por: Vieillard, Vincent, et al.
Publicado: (2017)

Interferon Gamma in African Trypanosome Infections: Friends or Foes?
por: Wu, Hui, et al.
Publicado: (2017)

Familial Mediterranean Fever and COVID-19: Friends or Foes?
por: Stella, Alessandro, et al.
Publicado: (2020)

Natural Killer Cells: Friend or Foe in Metabolic Diseases?
por: Li, Yi, et al.
Publicado: (2021)

Protein Kinase R in Bacterial Infections: Friend or Foe?
por: Smyth, Robin, et al.
Publicado: (2021)

Editorial: Innate Lymphoid Cells in Cancer: Friends or Foes?
por: Jacquelot, Nicolas, et al.
Publicado: (2021)

The tumor micro-environment in pediatric glioma: friend or foe?
por: Messiaen, Julie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_da2r7vd9hce8sab6ei3l26eg3k